Target intelligence / Profile preview

RNA, U6 small nuclear 840, pseudogene (RNU6-840P)

Target
RNU6-840P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNU6-840P is a pseudogene in the human genome corresponding to a non-functional copy of the U6 small nuclear RNA gene[1][4][7]. U6 snRNA is a critical RNA component of the spliceosome, required for pre-mRNA splicing; however, RNU6-840P lacks protein-coding potential and is not known to produce a functional RNA or protein product[1][4]. As a pseudogene, RNU6-840P is considered a genomic relic of the U6 snRNA gene and does not have the established biological activities or therapeutic relevance of the canonical, functional U6 snRNA gene[1][4][7]. There is no evidence supporting a direct role of RNU6-840P in normal biological processes or disease, and it is not considered a druggable or therapeutic target. Clarifications: - This entry refers specifically to a pseudogene, not the functional U6 snRNA or its protein complexes[1][4][7]. - Pseudogenes like RNU6-840P may sometimes have regulatory RNA roles in principle (e.g., as competing endogenous RNAs), but no evidence currently supports such a function for this specific pseudogene[1][4][7][6]. - The pseudogene is not associated with drugs, disease roles, biomarkers, or known safety concerns in therapeutic contexts. Summary: RNU6-840P is a non-coding RNA pseudogene representing a non-functional copy of the U6 small nuclear RNA gene, with no established role as a therapeutic target, biomarker, or disease gene in current biomedical knowledge[1][4][7].

Other names
RNU6-840PU6 snRNA pseudogene 840U6 small nuclear RNA pseudogene 840

Beyond the preview

Go deeper on RNA, U6 small nuclear 840, pseudogene (RNU6-840P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 840, pseudogene (RNU6-840P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call